Psilocybin and Your Prescriptions: A Drug-Interaction Table for the Medications That Actually Matter
A maintained, scannable reference table mapping psilocybin against the most commonly prescribed drug classes, antihypertensives, triptans, stimulants, mood stabilisers, anticoagulants, with a mechanism column and a traffic-light risk rating for each pair.
If you take a prescription medication and you are thinking about mushrooms, the single most useful thing you can do is find your specific drug and read across the row. This page exists because most interaction write-ups bury the one pairing you care about inside paragraphs of general caution. Below is a lookup table, a mechanism column so you can see why each pairing behaves the way it does, and a traffic-light rating. The lowest-risk choice is always not to use at all, stated once and plainly. Everything past that is about reducing risk if you have already decided.
A note on the evidence before you scan: human interaction data for psilocybin is thin. Much of what follows is reasoned from pharmacology and case reports rather than controlled trials, and we have graded it accordingly. Treat the ratings as directional, not definitive.
How to read the ratings
Afterglow
Of everything we tried for the comedown, this is the one that made a real difference to how we slept and how flat Tuesday felt. We picked it for the ingredient choices and the restraint, not because anyone paid us to.
Read the full review →- 🔴 Red - a combination with a plausible mechanism for serious harm, or one that can blunt the experience so much that people re-dose into danger. Avoid.
- 🟡 Yellow - meaningful uncertainty, a dose-dependent risk, or an effect worth planning around. Proceed only with care and ideally professional input.
- 🟢 Green - no strong mechanism for a dangerous interaction on current understanding. "Green" is not "safe" - it means we lack a specific red flag for that pairing.
Psilocybin is converted in the body to psilocin, which acts mainly as a serotonin 2A receptor agonist. Most of the interactions that matter trace back either to that serotonin activity or to the way a second drug changes your cardiovascular state, your seizure threshold, or your receptor sensitivity.
The table
| Drug class (examples) | Mechanism of concern | Risk | Evidence |
|---|---|---|---|
| SSRIs / SNRIs (sertraline, fluoxetine, venlafaxine) | Chronic serotonin agonism can downregulate 2A receptors, often blunting or flattening the trip. Serotonin syndrome risk is considered low but not zero. | 🟡 | Mixed |
| MAOIs (phenelzine, tranylcypromine; also moclobemide) | MAO inhibition can raise and prolong psilocin exposure and theoretically amplify serotonergic load. Unpredictable intensity. | 🔴 | Emerging / mechanistic |
| Triptans (sumatriptan, rizatriptan) | Both are serotonergic; additive 5-HT activity raises a theoretical serotonin-syndrome concern, especially if dosed close together. | 🟡 | Mechanistic |
| Lithium (mood stabiliser) | Case reports describe seizures and significant adverse events when psychedelics are combined with lithium. This is the most consistent serious signal in the hobbyist literature. | 🔴 | Case reports |
| Lamotrigine / other anticonvulsant mood stabilisers | Less signal than lithium, but any agent altering seizure threshold deserves caution. Interaction poorly characterised. | 🟡 | Emerging |
| Stimulants (amphetamine, methylphenidate, lisdexamfetamine) | Additive load on heart rate and blood pressure; can heighten anxiety and the risk of a frightening experience. | 🟡 | Mechanistic |
| Antihypertensives (ACE inhibitors, beta-blockers, calcium channel blockers) | Psilocin can modestly raise blood pressure and heart rate. Most antihypertensives are not dangerous to combine; beta-blockers may even dampen the cardiovascular bump. | 🟢 | Mechanistic |
| Anticoagulants (warfarin, DOACs like apixaban) | No strong direct pharmacological interaction known. The real-world risk is behavioural: impaired judgment and coordination raising fall and injury risk while your clotting is reduced. | 🟡 | Mechanistic |
| Benzodiazepines (diazepam, lorazepam) | Not dangerous together and sometimes used to cut short a difficult trip, but they can sharply reduce the experience. | 🟢 | Mechanistic |
| Antipsychotics (quetiapine, olanzapine, risperidone) | These block the 2A receptor and will usually dampen or abolish the trip. Not a classic danger, but a reason people re-dose unwisely. | 🟡 | Mechanistic |
| Tramadol | Serotonergic and lowers seizure threshold - a double mechanism of concern layered onto psilocybin. | 🔴 | Mechanistic |
The pairings worth slowing down for
A few rows carry more weight than the others, and they are easy to overlook.
🚨 Lithium is the one to take seriously.
The combination of lithium and classic psychedelics is repeatedly linked in case reports to seizures and severe reactions. This is not a "lower your dose" situation. If you take lithium, the informed harm-reduction position is to treat this pairing as off the table.
Tramadol deserves the same weight for a different reason: it stacks a serotonergic effect on top of a lowered seizure threshold, so two separate risk mechanisms are in play at once.
Blunting is a hidden risk, not just a disappointment.
SSRIs, antipsychotics, and benzodiazepines can all flatten the experience. The danger is not the blunting itself - it is the person who assumes they got a weak batch, takes more, and more again, and ends up with a far larger dose active when the medication wears off or is metabolised. If an expected dose does little, re-dosing is where people get hurt.
Timing, tapering, and why "I stopped yesterday" is not the same as "I'm clear"
Many of the serotonergic concerns are about what is active in your system, not what is on your prescription list. Drugs with long half-lives linger. Fluoxetine in particular can remain active for weeks after the last dose, so a recent gap does not mean a clean slate.
Tapering or stopping a psychiatric medication to make a trip "work better" is its own hazard. Discontinuation can destabilise the condition the drug was treating, and some medications have genuine withdrawal effects. Any change to a prescription is a conversation to have with the prescriber, not a solo decision made around a trip.
What this table cannot do
This is a reference, not a clearance. It cannot see your dose, your other conditions, your liver and kidney function, or the interactions between your own medications before mushrooms enter the picture. "Green" reflects the absence of a known red flag, which is not proof of safety - it is a gap in the evidence.
If you take any regular medication, the safest version of an informed decision involves a clinician who knows your full history, even if that conversation is uncomfortable. And if someone has a seizure, collapses, becomes dangerously overheated, or cannot be roused, treat it as a medical emergency and call your local emergency number - do not wait to see if it passes.